Cadrenal Therapeutics Inc...
(CVKD)
undefined
undefined%
At close: undefined
11.25
0.45%
After-hours Dec 13, 2024, 04:23 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 |
Net Income | -8.36M | -6.71M |
Depreciation & Amortization | 1.98K | 1.27K |
Stock-Based Compensation | 710.38K | - |
Other Working Capital | 381.89K | 202.84K |
Other Non-Cash Items | 3.97M | 4.50M |
Deferred Income Tax | - | - |
Change in Working Capital | 144.31K | 607.74K |
Operating Cash Flow | -3.53M | -1.20M |
Capital Expenditures | -3.25K | - |
Acquisitions | - | - |
Purchase of Investments | - | -2.28K |
Sales Maturities Of Investments | - | - |
Other Investing Acitivies | - | - |
Investing Cash Flow | -3.25K | -2.28K |
Debt Repayment | -250.00K | - |
Common Stock Repurchased | - | - |
Dividend Paid | - | - |
Other Financial Acitivies | 250.00K | - |
Financial Cash Flow | 11.90M | 1.24M |
Net Cash Flow | 8.37M | 32.59K |
Free Cash Flow | -3.53M | -1.20M |